The European Generics Association will be hosting the 8th EGA Legal Affairs Forum between the 22 and 23 March 2012 in Brussels.
It will feature an interesting programme including:
Recent developments on SPCs:
• SPCs caselaw and legislation update
- – The galanthamine and the memantine decisions
- – The Medeva and the Georgetown references to the CJEU
- – Paediatric extensions: negative term SPCs
• Combination products in the pipeline
- – the effect of the Medeva judgment
• Litigating SPCs around Europe – escitalopram case study
- – What is the product/active ingredient? Regulatory and litigation strategies
• Roundtable presentations on national escitalopram SPC cases: Germany, France, The Netherlands, Belgium
Maximising legal professional privilege:
• Privilege in litigation in Europe
(General overview, comparing approach in different Member States)
• Privilege and European Commission investigations/patent settlement cases
(The Akzo Nobel case, practical issues arising from investigations – privilege and disclosure, update on the Commission’s investigations into patent settlements)
Patent enforcement in Europe:
- Views on the review of Directive 2004/48/EC on the enforcement of IP rights
- Views on the changes in the EU patent system: single court and patent with unitary effect
- Update on court cases that impact the industry
The Full Programme can be found here and it starts with a welcome buffet lunch sponsored by Bird & Bird.
